the aid library

LIST OPTIONS

Filter

1091

Sort by:

Direction:

Download (1069)

View PDF (1589)

Regional Guidelines for the Management of Severe Falciparum Malaria in Small Hospitals

Polrat Wilairatana, Srivicha Krudsood, Ma. Sandra B. Tempongko et al. WHO South-East Asia New Delhi (2006)

Download (173)

View PDF (166)

Childhood Tuberculosis: Diagnosis, Treatment and Prevention of TB in HIV-infected Children

C. DC Christie-Samuels World Health Organization (2019) C_WHO

Accessed: 21.10.2019

Download (182)

View PDF (265)

Cross-Cultural Variance of Schizophrenia in Symptoms, Diagnosis and Treatment

Banerjee, A. (2012) C2

The Georgetown Undergraduate Journal of Health Services (2), 2012.

Download (355)

View PDF (695)

National Guidelines for the Treatment of Malaria, South Africa 2019

National Department of Health, South Africa (2019) C1

Download (233)

View PDF (262)

Developmental Disabilities

Institute of Medicine (US); Committee on Nervous System Disorders in Developing Countries; National Academy of Sciences (2001) C2

Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries. Washington (DC): National Academies Press (US); 2001.

Download (597)

View PDF (696)

Guidelines for Diagnosis and Treatment of Malaria in India 2014

NATIONAL INSTITUTE OF MALARIA RESEARCH NEW DELHI (2014) C1

Download (263)

View PDF (151)

Standard treatment guidelines Otorhinolarygology (ENT)

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr.6, 2020

Download (94)

View PDF (134)

Rapport mondial 2020 : Agissons maintenant - Pour combattre les profondes inégalités et mettre fin aux pandémies
recommended

ONUSIDA (2020) C_WHO

Objectifs 2020 : des avancées disparates. Le rapport de l’ONUSIDA sur l’épidémie mondiale de sida fait état d’un échec accentué par la COVID-19. Depuis 2015, 3,5 millions d’infections au VIH et 820 000 morts supplémentaires liés au sida sont imputables à des objectifs non atteints. ... more

Download (176)

View PDF (181)

Treatment of Malaria (Guidelines for Clinicians)

Centers for Disease Control and Prevention CDC (2019) C_CDC

Because malaria cases are seen relatively rarely in North America, misdiagnosis by clinicians and laboratorians has been a commonly documented problem in published reports. However, malaria may be a common illness in areas where it is transmitted and therefore the diagnosis of malaria should routine... more

Download (87)

View PDF (130)

Diagnostic testing for SARS-CoV-2: interim guidance, 11 September 2020

World Health Organization WHO (2020) C_WHO

Available in Arabic, Chinese, English, French, Portuguese and Spanish https://apps.who.int/iris/handle/10665/334254

Download (97)

View PDF (181)

Note of the Vatican Covid-19 Commission in collaboration with the Pontifical Academy for Life “Vaccine for all. 20 points for a fairer and healthier world"

Vatican COVID-19 Commission; Pontifical Academy for Life (2021) CC

Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world

Download (334)

View PDF (241)

Emergency Illnesses and Major Injuries Affecting Infants and Children; Including Adolescent Girls Who Are Pregnant

Maternal & Childhealth Advocacy International MCAI (2021) C1

Handbook 1

Download (93)

View PDF (126)

Notes on the identification, diagnosis and treatment of patients with COVID-19
recommended

Robert-Koch-Institut RKI (2021) C1

16.7.2021

Download (129)

View PDF (167)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (120)

View PDF (181)

National Guidelines for the Treatment of Malaria - 2019

South African Malaria Elimination Committee (SAMC) National Department of Health South Africa (2019) CC

These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa... more

Download (105)

View PDF (169)

WHO Meeting on Buruli ulcer and other skin NTDs. Final report.

World Health Organization WHO (2019) C_WHO

The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019

Download (170)

View PDF (215)

Commentary: Chagas Disease — An Underestimated Global Public Health Challenge

Liu, Q., Chen, M., Zhou, X. China CDC Weekly (2020) C_CDC

American trypanosomiasis, commonly called Chagas disease (CD), was prevalent once in rural areas of Latin America where poverty is widespread and was considered a silent and poorly visible disease. It has become a global neglected tropical disease and a significant public health th... more

Download (150)

View PDF (123)

National Guidelines - Diagnosis, Case Management Prevention and Control of Leptospirosis

National Centre for Disease Control - Delhi (2015) C2

Diagnosis, Case Management Prevention and Control of Leptospirosis

Download (105)

View PDF (121)

Diphtheria - Vaccine-Preventable Diseases Surveillance Standards

World Health Organization WHO (2018) C_WHO

Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall... more

Download (20)

View PDF (67)

Proposed Strategies to Improve Adult Asthma Management in Egypt: Expert Review and Recommendations

Hosny, H.; Madkour, A.; Hantera, M.; et al. (2022) CC2

Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G... more

Rapport mondial 2020 : Agissons maintenant - Pour combattre les profondes inégalités et mettre fin aux pandémies recommended

Notes on the identification, diagnosis and treatment of patients with COVID-19 recommended

Rapport mondial 2020 : Agissons maintenant - Pour combattre les profondes inégalités et mettre fin aux pandémies
recommended

Notes on the identification, diagnosis and treatment of patients with COVID-19
recommended